Whitener Capital Management’s GSK GSK Stock Holding History

Whitener Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,452	Closed	-$202K	–	123
2019 Q4	$202K	Buy	3,452 +534	+18%	+$29.7K	0.1%	136
2019 Q3	$155K	Sell	2,918 -360	-11%	-$18.5K	0.09%	141
2019 Q2	$164K	Sell	3,278 -520	-14%	-$26.1K	0.09%	138
2019 Q1	$198K	Hold	3,798	–	–	0.13%	119
2018 Q4	$181K	Buy	3,798 +111	+3%	+$5.47K	0.13%	121
2018 Q3	$185K	Buy	+3,687	New	+$187K	0.12%	129
2018 Q2	–	Sell	-3,443	Closed	-$168K	–	226
2018 Q1	$168K	Buy	3,443 +2,928	+569%	+$136K	0.13%	127
2017 Q4	$22K	Buy	+515	New	+$23.8K	0.02%	246

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Whitener Capital Management's GSK Position: Q1 2020 in Review

Whitener Capital Management sold out of GSK (GSK) in Q1 2020, closing a stake of 3,452 shares — an estimated $202K sold.

Whitener Capital Management first reported a position in GSK in Q4 2017 and held it in 8 quarters. The position peaked at $202K in Q4 2019. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Whitener Capital Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Whitener Capital Management sold 3,452 GSK shares in Q1 2020, an estimated $202K.
Whitener Capital Management first reported a position in GSK in Q4 2017 and held it in 8 quarters.
Whitener Capital Management's GSK position peaked at $202K in Q4 2019.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Whitener Capital Management's 13F filing for Q1 2020, filed 24 Apr 2020.